Herein, we show that in vivo passage has led to a hepatocellular carcinoma cell line with enhanced tumorigenicity and EpCAM expression, hallmark characteristics of tumor initiating cells (TIC). This evidence concerns the gene EPCAM and hepatocellular carcinoma.